Amgen Scholars Program
print

Links and Functions

Breadcrumb Navigation


Content

Molecular Medicine

Surname, First name Research Focus Availability
Ertürk, Ali We develop technologies to solve some of the major bottlenecks around science by developing novel imaging technologies. Our general approach to science is to combine biomedical research with artificial intelligence (AI), and nanotechnology. available in 2022
Michalakis, Stylianos The overarching goal will be to establish and manipulate an in vitro retinal model for the evaluation of innovative therapeutic approaches for blinding eye disorders. available in 2022
Misgeld, Thomas The Misgeld lab uses in vivo imaging methods (ranging from wide-field time-lapse to two-photon microscopy) to study the development and degeneration of neurons and their processes. TBA
Plesnila, Nikolaus The main interest of the laboratory is to study the role of cerebral vessels for the pathophysiology of acute and chronic brain injury and to use the evolving knowledge for the development of novel therapeutic strategies for patients. For this purpose we use clinically relevant mouse models for acute and chronic brain injury and investigate neuro-vascular morphology and function by in vivo microscopy using conventional and 2-photon fluorescence microscopy. available in 2022
Ploner, Markus On a systems neuroscience level we are working on the brain mechanisms of pain perception. We aim to further the understanding of the brain processes, which determine the individual sensitivity of a person to pain, which explain why we perceive the same painful event differently in different situations. not available
Sattler, Michael We study the structure, molecular recognition and dynamics of biomolecules in solution using Nuclear Magnetic Resonance (NMR) spectroscopy, combined with complementary structural biology and biophysical techniques. TBA
Schmidt, Mathias V. The main focus of this research group is to study the impact of acute and chronic stress on the body during different developmental stages. Specifically, we are interested in the behavioral, neuroendocrine and molecular basis of individual stress vulnerability and resilience. available in 2022
Thorn-Seshold, Oliver Our group uses organic chemistry to create small molecule reagents for cell biology research, and targeted therapeutics for translational medicine. TBD
Tiedt, Steffen We aim to identify circulating signatures that inform on the local and systemic effects of stroke and to explore the underlying molecular and pathophysiological mechanisms. Events in most organs including the local and systemic events (e.g. stress) related to acute stroke are captured by the circulating proteome and metabolome. available in 2022
Vollmar, Angelika The biochemical pathway of chlorophyll degradation has only recently been characterized. The metabolites that are yielded from the breakdown path – the phyllobilins – were shown to have antioxidant properties. available in 2022
Wagner, Ernst Novel molecular therapeutics like siRNA, microRNAs or antagomiRs require potent extracellular and intracellular delivery devices to be effective antitumor agents. TBA
Willem, Michael The Laboratory for Neurodegenerative Disease Research focuses on the generation of Amyloid ß-peptide (Aß) as the major constituent of neurotoxic amyloid plaques in Alzheimer's Disease (AD). TBA